IL4

Across TCGA pan-cancer cohorts, IL4 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated IL4 data layer compared with 21 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IL4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated IL4 expression acts as an unfavorable survival marker.

HNSC, COAD, and LIHC are the cancer types where IL4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.101	0.710	<.001	24	view →
COAD	OS	Median	All	0.371	0.871	<.001	21	view →
LIHC	OS	Median	III,IV	0.270	0.732	.021	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

IL4–HNSC (DFS)

Open the HNSC breakdown →